Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature

Salma B. Abdelbaky, Brian Giacopelli, Kari G. Rabe, Kyoko Yamaguchi, Yue-Zhong Wu, Huihuang Yan, Tait D. Shanafelt, Sameer A. Parikh, Wei Ding, Paul J. Hampel, Sochilt Brown, James R. Cerhan, Celine M. Vachon, Neil E. Kay, Curtis A. Hanson, Alexander S. Parker, Esteban Braggio, Susan L. Slager, Christopher C. Oakes

Blood (2024) 143 (17): 1752–1757.

https://doi.org/10.1182/blood.2023022180

Published: 2024

Includes: Supplemental data

Journal Articles

DNA Methylation-Based Classification of Hairy Cell Leukemia and Splenic B Cell Lymphoma

Blood (2023) 142 (Supplement 1): 174.

https://doi.org/10.1182/blood-2023-189835

Published: 2023

Journal Articles

Methylome Analysis of Epstein-Barr Virus with Nanopore Sequencing Reveals Viral State Dynamics

Christoph Weigel, Esko Kautto, Elshafa H. Ahmed, Yue-Zhong Wu, Charles T. Gregory, Ada C. Cleary, Sarah Y. Schlotter, Eric Brooks, Mark Lustberg, Robert A. Baiocchi, James S. Blachly, Christopher C. Oakes

Blood (2022) 140 (Supplement 1): 8772–8773.

https://doi.org/10.1182/blood-2022-159739

Published: 2022

Journal Articles

Epigenetic Phenocopying Expands Molecular Risk Assessment in Acute Myeloid Leukemia (Alliance)

Blood (2021) 138 (Supplement 1): 803.

https://doi.org/10.1182/blood-2021-147652

Published: 2021

Journal Articles

Developmental DNA Methylation Subtype Predicts Progression to Treatment and Survival in High-Count Monoclonal B Lymphocytosis

Brian Giacopelli, BS, Kari G. Chaffee, MS, Yue-zhong Wu, MSc, John C. Byrd, MD, Tait D. Shanafelt, MD, Sameer A. Parikh, MD, Esteban Braggio, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Christopher C. Oakes, PhD

Blood (2019) 134 (Supplement_1): 3022.

https://doi.org/10.1182/blood-2019-123564

Published: 2019

Journal Articles

DNA Methylation-Based Classification Highlights the Role of the JAK-STAT Pathway in Acute Myeloid Leukemia

Brian Giacopelli, BS, Min Wang, Ada C Cleary, Yue-zhong Wu, MSc, Anna Reister Schultz, James S. Blachly, MD, Ann-Kathrin Eisfeld, MD, Kevin R Coombes, Clara D. Bloomfield, MD, Brian J. Druker, Jeffrey W. Tyner, John C. Byrd, MD, Christopher C. Oakes, PhD

Blood (2019) 134 (Supplement_1): 1413.

https://doi.org/10.1182/blood-2019-126212

Published: 2019

Journal Articles

Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia

Blood (2019) 134 (8): 688–698.

https://doi.org/10.1182/blood.2019000490

Published: 2019

Includes: Supplemental data

Journal Articles

Recurrent Mutations in EGR2 Direct Specific Epigenetic Reconfiguration in Chronic Lymphocytic Leukemia

Blood (2018) 132 (Supplement 1): 650.

https://doi.org/10.1182/blood-2018-99-119070

Published: 2018

Journal Articles

Aberrant Methylation and Decreased Expression of NRIP1 in IGHV -Unmutated CLL

Madelyn Gerber, PhD, Yali Zhu, PhD, Yue-Zhong Wu, MAS, Brian Giacopelli, BS, Kevin Coombes, PhD, Christopher C Oakes, PhD, Lynne V. Abruzzo, MD PhD

Blood (2016) 128 (22): 1527.

https://doi.org/10.1182/blood.V128.22.1527.1527

Published: 2016

Journal Articles

Comparative Evaluation of Prognostic Factors That Assess the Natural History of Chronic Lymphocytic Leukemia

Brian Giacopelli, BS, Amy S. Ruppert, MAS, Yue-Zhong Wu, MAS, Laura Z. Rassenti, PhD, William G. Wierda, MD PhD, Kanti R Rai, MD, Neil E. Kay, MD, Jennifer R. Brown, Thomas J. Kipps, MD, PhD, John C. Byrd, MD, Christopher C Oakes, PhD

Blood (2016) 128 (22): 968.

https://doi.org/10.1182/blood.V128.22.968.968

Published: 2016

Journal Articles

Targeting Mir-155 via The NEDD8-Activating Enzyme Inhibitor MLN4924: A Novel Therapeutic Approach For Acute Myeloid Leukemia (AML)

Jihane C Khalife, MS, Hanna S Radomska, PhD, Jennifer Saultz, MD, Ramasamy Santhanam, PhD, Xiaomeng Huang, Hongyan Wang, PhD, John P. Curfman, Yue-Zhong Wu, MS, Pia Hoellerbauer, Houda Alachkar, PharmD, PhD, Adrienne M Dorrance, Ph.D, Michael A. Caligiuri, MD, Ramiro Garzon, MD, Jason H. Mendler, MD, PhD, Guido Marcucci, MD

Blood (2013) 122 (21): 3804.

https://doi.org/10.1182/blood.V122.21.3804.3804

Published: 2013

Journal Articles

Differential Clinical Impact Of Gene Mutations and Their Combinations In Primary Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Blood (2013) 122 (21): 2540.

https://doi.org/10.1182/blood.V122.21.2540.2540

Published: 2013

Journal Articles

inv(16)/t(16;16) acute myeloid leukemia with non–type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations

Blood (2013) 121 (2): 385–391.

https://doi.org/10.1182/blood-2012-07-442772

Published: 2013

Includes: Supplemental data

Journal Articles

Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia

Blood (2013) 121 (1): 159–169.

https://doi.org/10.1182/blood-2012-05-428573

Published: 2013

Includes: Supplemental data

Journal Articles

The Clinical Role of Micrornas (miRs) in Cytogenetically Normal (CN) Acute Myeloid Leukemia (AML): miR-155 Upregulation Independently Identifies High-Risk Patients (Pts)

Blood (2012) 120 (21): 1387.

https://doi.org/10.1182/blood.V120.21.1387.1387

Published: 2012

Journal Articles

Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia

Blood (2012) 120 (12): 2466–2474.

https://doi.org/10.1182/blood-2012-05-429175

Published: 2012

Includes: Supplemental data

Journal Articles

miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia

Blood (2012) 120 (2): 249–258.

https://doi.org/10.1182/blood-2012-02-408492

Published: 2012

Includes: Supplemental data

Journal Articles

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

Blood (2011) 118 (26): 6920–6929.

https://doi.org/10.1182/blood-2011-08-368225

Published: 2011

Includes: Supplemental data

Journal Articles

Impact of DNMT3A mutations on Clinical Response to the Hypomethylating Agent Decitabine in Older Patients (pts) with Acute Myeloid Leukemia (AML)

Alison R. Walker, MD, Klaus H. Metzeler, MD, Susan Geyer, PhD, Heiko Becker, MD, Sebastian Schwind, MD, Susan P. Whitman, PhD, John Curfman, Yue-Zhong Wu, MS, Danilo Perrotti, MD, Ph.D, Rebecca B. Klisovic, MD, Ramiro Garzon, MD, William Blum, MD, Guido Marcucci, MD

Blood (2011) 118 (21): 944.

https://doi.org/10.1182/blood.V118.21.944.944

Published: 2011

Journal Articles

Cytogenetic, Molecular and Clinical Features Associated with Rare CBFB-MYH11 Fusion Transcripts in Patients (Pts) with Acute Myeloid Leukemia (AML) and inv(16)/t(16;16)

Colin G Edwards, PhD, Kati Maharry, MAS, Krzysztof Mrózek, MD, PhD, Sebastian Schwind, MD, Peter Paschka, MD, Deedra Nicolet, MS, Jessica Kohlschmidt, PhD, Thomas W Prior, PhD, Yue-Zhong Wu, MS, Jonathan E. Kolitz, MD, William Blum, MD, Mark J. Pettenati, PhD, Paola Dal Cin, PhD, Andrew J. Carroll, PhD, Michael A Caligiuri, MD, Richard A. Larson, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD

Blood (2011) 118 (21): 2514.

https://doi.org/10.1182/blood.V118.21.2514.2514

Published: 2011

NARROW

Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature

DNA Methylation-Based Classification of Hairy Cell Leukemia and Splenic B Cell Lymphoma

Methylome Analysis of Epstein-Barr Virus with Nanopore Sequencing Reveals Viral State Dynamics

Epigenetic Phenocopying Expands Molecular Risk Assessment in Acute Myeloid Leukemia (Alliance)

Developmental DNA Methylation Subtype Predicts Progression to Treatment and Survival in High-Count Monoclonal B Lymphocytosis

DNA Methylation-Based Classification Highlights the Role of the JAK-STAT Pathway in Acute Myeloid Leukemia

Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia

Recurrent Mutations in EGR2 Direct Specific Epigenetic Reconfiguration in Chronic Lymphocytic Leukemia

Aberrant Methylation and Decreased Expression of NRIP1 in IGHV -Unmutated CLL

Comparative Evaluation of Prognostic Factors That Assess the Natural History of Chronic Lymphocytic Leukemia

Targeting Mir-155 via The NEDD8-Activating Enzyme Inhibitor MLN4924: A Novel Therapeutic Approach For Acute Myeloid Leukemia (AML)

Differential Clinical Impact Of Gene Mutations and Their Combinations In Primary Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

inv(16)/t(16;16) acute myeloid leukemia with non–type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations

Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia

The Clinical Role of Micrornas (miRs) in Cytogenetically Normal (CN) Acute Myeloid Leukemia (AML): miR-155 Upregulation Independently Identifies High-Risk Patients (Pts)

Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia

miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

Impact of DNMT3A mutations on Clinical Response to the Hypomethylating Agent Decitabine in Older Patients (pts) with Acute Myeloid Leukemia (AML)

Cytogenetic, Molecular and Clinical Features Associated with Rare CBFB-MYH11 Fusion Transcripts in Patients (Pts) with Acute Myeloid Leukemia (AML) and inv(16)/t(16;16)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only